Alpha Teknova, Inc. (TKNO)
USD 6.43
(4.05%)
USD 6.43
(4.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 10.29 Million USD | -47.65% |
| 2022 | 17.47 Million USD | -0.82% |
| 2021 | 17.62 Million USD | -0.75% |
| 2020 | 17.75 Million USD | 107.08% |
| 2019 | 8.57 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.92 Million USD | 83.57% |
| 2024 Q2 | 2.8 Million USD | 45.89% |
| 2023 Q2 | 5.06 Million USD | 109.08% |
| 2023 Q1 | 2.42 Million USD | 14.83% |
| 2023 FY | 9.14 Million USD | -47.65% |
| 2023 Q4 | 1.04 Million USD | -28.87% |
| 2023 Q3 | 1.47 Million USD | -70.94% |
| 2022 Q2 | 5.24 Million USD | -1.91% |
| 2022 FY | 17.47 Million USD | -0.82% |
| 2022 Q1 | 5.34 Million USD | 7.43% |
| 2022 Q3 | 4.77 Million USD | -9.09% |
| 2022 Q4 | 2.11 Million USD | -55.77% |
| 2021 Q4 | 4.97 Million USD | 16.8% |
| 2021 Q1 | 5.02 Million USD | -9.77% |
| 2021 FY | 17.62 Million USD | -0.75% |
| 2021 Q2 | 3.35 Million USD | -33.25% |
| 2021 Q3 | 4.26 Million USD | 27.1% |
| 2020 Q1 | 3.62 Million USD | 0.0% |
| 2020 FY | 17.75 Million USD | 107.08% |
| 2020 Q4 | 5.56 Million USD | 9.45% |
| 2020 Q3 | 5.08 Million USD | 46.67% |
| 2020 Q2 | 3.46 Million USD | -4.41% |
| 2019 FY | 8.57 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 65.394% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 96.843% |
| Journey Medical Corporation | 52.52 Million USD | 80.396% |
| Dynavax Technologies Corporation | 182.11 Million USD | 94.346% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 85.909% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 97.609% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 97.9% |
| PainReform Ltd. | -15 Thousand USD | 68740.0% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -145.659% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -23.466% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -23.466% |
| SCYNEXIS, Inc. | 124.51 Million USD | 91.731% |
| Silver Spike Investment Corp. | 8.1 Million USD | -27.07% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -1758.581% |
| Alvotech | -69.42 Million USD | 114.831% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 96.628% |
| Bright Green Corporation | -237.01 Thousand USD | 4444.011% |
| Embecta Corp. | 749.9 Million USD | 98.627% |
| Safety Shot Inc | -74.45 Thousand USD | 13928.116% |
| Procaps Group, S.A. | 239.56 Million USD | 95.702% |
| Cosmos Health Inc. | 4.34 Million USD | -136.713% |
| Theratechnologies Inc. | 62.12 Million USD | 83.428% |
| Harrow Health, Inc. | 90.55 Million USD | 88.63% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -116.986% |
| Biofrontera Inc. | 16.62 Million USD | 38.077% |
| DURECT Corporation | 6.83 Million USD | -50.725% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 98.034% |
| Cronos Group Inc. | 6.99 Million USD | -47.277% |
| OptiNose, Inc. | 62.35 Million USD | 83.488% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 97.666% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 3498.02% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -237.113% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 96.676% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -90.86% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 69.253% |
| Radius Health, Inc. | 307.71 Million USD | 96.654% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -2.164% |
| ProPhase Labs, Inc. | 16.23 Million USD | 36.597% |
| Phibro Animal Health Corporation | 312.48 Million USD | 96.705% |
| Procaps Group S.A. | 239.56 Million USD | 95.702% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -690.783% |
| Viatris Inc. | 6.43 Billion USD | 99.84% |
| Rockwell Medical, Inc. | 8.7 Million USD | -18.29% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 81.138% |
| SIGA Technologies, Inc. | 122.09 Million USD | 91.567% |
| Tilray Brands, Inc. | 223.35 Million USD | 95.39% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 75.398% |
| Shineco, Inc. | 882.16 Thousand USD | -1067.125% |
| PetIQ, Inc. | 252.74 Million USD | 95.926% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 1480.924% |
| Incannex Healthcare Limited | 12 Thousand USD | -85700.0% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 99.443% |
| Alimera Sciences, Inc. | 61.17 Million USD | 83.168% |
| Assertio Holdings, Inc. | 125.04 Million USD | 91.766% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 151267.229% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -57.047% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 527.189% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 62.031% |
| Hempacco Co., Inc. | -1.21 Million USD | 946.827% |
| Talphera, Inc. | -4.89 Million USD | 310.337% |
| Alvotech | -69.42 Million USD | 114.831% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 95.355% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 98.549% |
| Currenc Group, Inc. | 17.35 Million USD | 40.679% |
| Kamada Ltd. | 52.59 Million USD | 80.423% |
| Indivior PLC | 907 Million USD | 98.865% |
| Evoke Pharma, Inc. | 4.97 Million USD | -106.799% |
| Flora Growth Corp. | 17.73 Million USD | 41.955% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 527.189% |
| Evolus, Inc. | 140.52 Million USD | 92.673% |
| HUTCHMED (China) Limited | 453.55 Million USD | 97.73% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 97.007% |
| Akanda Corp. | 111.44 Thousand USD | -9138.306% |